Psychedelic Business Spotlight – February 18
This week in psychedelic business news: Nova Mentis makes progress on autism; atai donates to MAPS; Cathie Wood eyes more psychedelic stocks.
MAPS
Interview with Rick Doblin, Executive Director and Founder of MAPS
In this episode, Rick and James Hallifax discuss MAPS’ work treating PTSD with MDMA, sending the Soviets Psychedelics, and what the future holds.
How Rick Doblin Guides Someone Through a Bad Psychedelic Trip
Difficult trips could be a problem in areas where psychedelics have been decriminalized, which is why MAPS will offer a psychonaut training program.
2021: A Year in Review for the Psychedelics Business
Our resident Psychedelic Investor looks back at some of this growing industry’s biggest moments and how they may shape the business in 2022.
Psychedelic Business Spotlight – December 17
This week in psychedelic business news: Cybin steps closer to a new patent; MindMed appoints new CEO; MAPS and Wesana Health resume negotiations.
Psychedelic Business Spotlight: December 3
This week in psychedelic business news: MAPS pioneers new funding structure; FDA green lights a Cybin study for Covid-19 distress; Compass Pathways gets new majority stakeholder.
Celebrities: Are They Helping or Harming the Psychedelic Movement?
Two industry insiders weigh in on the question as more and more of the world’s biggest stars publicly share psychedelic experiences.
Veteran Who Cured PTSD with MDMA-Assisted Therapy Wows NBC ‘Today’ Show Anchors
“This treatment is the reason that my son has a father instead of a folded flag,” a once-suicidal Iraq War veteran tells Savannah Guthrie.
Are We Being Exposed to Psychedelics More Than Ever Before? Survey Says…It’s Complicated
A study of American newspaper mentions of psychedelics doesn’t stack up to what leaders in the industry are observing in the media landscape at large.
Driver’s Licenses to Trip on Psychedelics by 2035? Rick Doblin Maps Out the Future of ‘Spiritualized Humanity’
The MAPS founder, who will speak at psychedelic conference Wonderland Miami next month, predicts clinics that administer the medicines will become licensing bodies for personal use.
End of content
End of content